There is no healthy level of smoking

Acta Clinica Croatica

Volumn 48, Issue 3, 2009, Pages 371-376

  Čop Blažić, Nevenka ^a   Zavoreo, Iris ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Cerebrovascular disorders risk factors; Health status; Smoking adverse effects; Smoking prevention and control; Tobacco smoke pollution

Indexed keywords

NICOTINE;

BRAIN FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; HUMAN; PASSIVE SMOKING; REVIEW; RISK FACTOR; SMOKING CESSATION; TOBACCO DEPENDENCE;

CEREBROVASCULAR DISORDERS; HUMANS; RISK FACTORS; SMOKING;

EID: 74049152220     PISSN: 03539466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. WARD HJ, COUSENS SN, SMITH-BATHGATE B, LEITCH M, EVERINGTON D, WILL RG et al. Obstacles to conducting epidemiological research in the UK general population. BMJ 2004;328:277-9.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fourth Edition Text Revision. Washington, DC: American Psychiatric Association, 2000.
3. PICCIOTTO E, ZOLI M, RIMONDINI R, LENA C, MARUBIO LM et al. Mechanism of action of nicotine in the CNS. Nicotine Tob Res 1999;1:S121-S125.
4. YILDIZ D. Nicotine, its metabolism and an overview of its biological effects. Toxicon 2004;43:619-32.
5. DANI JA, HARRIS RA. Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nature Neurosci 2005;8:1465-70.
6. CORRINGER PJ, SALLETTE J, CHANGEUX JP. Nicotine enhances intracellular nicotinic receptor maturation: a novel mechanism of neural plasticity? J Phys 2006;99:162-71.
7. CAGGIULA AR, DONNY EC, CHAUDHRI N, PER-KINS KA, EVANS-MARTIN FF, SVED AF Importance of nonpharmacological factors in nicotine self-administration. Physiol Behav 2002;77:683-7.
8. GONZALES S, CASCIO MG, FERNANDEZ-RUIZ J, FEZZA F, DI MARZO V, RAMOS JA. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. JAMA 2006;296:47-55.
9. JORENBY DE, HAYS JT, RIGOTTI NA, AZOULAY S, WATSKY EJ, WILLIAMS KE et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006;296:56-63.
10. Erratum in: JAMA. 2006;296(11):1355.
11. WOLF PA, DAGOSTINO RB, KANNEL WB, BONITA R, BEL ANGER AJ. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988:259(7):1025-9.
12. GOLDSTEIN LB, ADAMS R, BECKER K, FURBERG CD, GORELICK PB, HADEMENOS G et al. Primary prevention of ischemic stroke. Stroke 2006;37:1583-633.
13. LAVI S, PRASAD A, YANG EH, MATHEW V, SIMARI RD, RIHAL CS et al. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation 2007;115:2621-7.
14. SAMBOLAA, OSENDE J, HATHCOCKJ, DEGENM, NEMERSON Y, FUSTER V et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 2003;107:973-7.
15. STEWART RAH, WHITE HD, KIRBY AC, HERITI-ER SR, SIMES RJ, NESTEL PJ ET AL. White blood cell count predicts reduction in coronary heart disease mortality with pravastatin. Circulation 2005;111:1756-62.
16. MORROW JD, FREI B, LONGMIRE AW, GAZIANO JM, LYNCH SM, SHYR Y et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers - smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198-203.
17. HOWARD G, WAGENKNECHT LE, BURKE GL, DIEZ-ROUX A, EVANS GW, MCGOVERN P. Cigarette Smoking and Progression of Atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA 1998;279:119-24.
18. SHINTON R, BEEVERS G. Meta-analysis of relation between cigarette smoking and stroke. N Engl J Med 1988;318:937-41.
19. HART CL, HOLE DJ, SMITH GD. Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley Study in Scotland. Stroke 1999;30:1999-2007.
20. KURTH T, KASE CS, BERGER K, GAZIANO JM, COOK NR, BURING JE. Smoking and risk of hemorrhagic stroke in women. Stroke 2003;34:2792-5.
21. ROBBINS TW, EVERITT BJ. Limbic-striatal memory systems and drug addiction. Neurobiol Learn Mem. 2002;78:625-36.
22. WHINCUP PH, GILGJA, EMBERSON JR, JARVIS MJ, FEYERABEND C, BRYANT A et al. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement BMJ 2004;329:200-5.
23. OTSUKA R, WATANABE H, HIRATA K, TOKAI K, MURO T, YOSHIYAMA M et al. Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA 2001;86:436-41.
24. HUNTER KA, GARLICK PJ, BROOM I, ANDERSON SE, MCNURLAN MA. Effects of smoking and abstention from smoking on fibrinogen synthesis in humans. Clin Sci 2001;100:459-65.
25. MORITA H, IKEDA H, HARAMAKI N, EGUCHI H, IMAIZUMI T. Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers. J Am Coll Cardiol 2005;45:589-94.
26. ELIASSON B, HJALMARSON A, KRUSE E, LAND-FELDT B, WESTIN A. Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob Res 2001;3:249-55.
27. OREN S, ISAKOV I, GOLZMAN B, KOGAN I, TURKOT S, PEL ED R et al. The influence of smoking cessation on hemodynamics and arterial compliance. Angiology 2006;57:564-8.
28. TwardellaD, Küpper-Nybelen J, Rothenbacher D, Hahmann H, Wüsten B, Brenner H. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements. Eur Heart J 2004;25:2101-8.
29. REA TD, HECKBERT SR, KAPLAN RC, SMITH NL, LEM AITRE RN, PSATY BM. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 2002;137:494-500